Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties

Clinical and Experimental Metastasis

Volumn 21, Issue 6, 2004, Pages 543-552

  Rae, James M ^a   Ramus, Susan J ^b   Waltham, Mark ^b,c   Armes, Jane E ^b   Campbell, Ian G ^b,c   Clarke, Robert ^e   Barndt, Robert J ^e   Johnson, Michael D ^e   Thompson, Erik W ^b,c,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d Bernard O'Brien Institute of Microsurgery   (Australia)

^e GEORGETOWN UNIVERSITY   (United States)

Author keywords

Breast cancer; Cell lines; Chromosomal number; MDA MB 435; Melanoma; Microsatellite analysis; Tyrosinase

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CANCER CENTER; CARCINOGENESIS; CHROMOSOME NUMBER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DNA FINGERPRINTING; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN GENOME; MELANOMA; MICROSATELLITE MARKER; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BREAST NEOPLASMS; DNA, NEOPLASM; FEMALE; GENE EXPRESSION; HUMANS; MELANOCYTES; MELANOMA; MICROSATELLITE REPEATS; NEOPLASM PROTEINS; NUCLEIC ACID HYBRIDIZATION; PLOIDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 12544252451     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10585-004-3759-1     Document Type: Article

References (31)

1. Cailleau R, Olive M, Cruciger QV. Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization. In Vitro 1978; 14(11): 911-15.
2. Price JE, Polyzos A, Zhang RD, Daniels LM. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 1990; 50(3): 717-21.
3. Price JE, Zhang RD. Studies of human breast cancer metastasis using nude mice. Cancer Metast Rev 1990; 8(4): 285-97.
4. Clarke R, Leonessa F, Brunner N, Thompson EW. In vitro models of human breast cancer. In Harris JR, Lippman ME, Morrow M, Hellman S (ed): Diseases of the Breast. Philadelphia: Lippincott, 1995.
5. Clarke R, Johnson M. Animal models. In Harris JR (ed): Diseases of the Breast, 2nd edition. Philadelphia: Lippincott Williams & Wilkins; 2000; 319-34.
6. Ross DT, Scherf U, Eisen MB et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000; 24(3): 227-35.
7. Jessani N, Liu Y, Humphrey M, Cravatt BF. Enzyme activity profiles of the secreted and membrane proteome that depict cancel-cell invasiveness. Proc Natl Acad Sci USA 2002; 99(16): 10335-40.
8. Lee H, Lin EC, Liu L, Smith JW. Gene expression profiling of tumor xenografts: In vivo analysis of organ-specific metastasis. Int J Cancer 2003; 107(4): 528-34.
9. Ellison G, Klinowska T, Westwood RF et al. Further evidence to support the melanocytic origin of MDA-MB-435. Mol Pathol 2002; 55(5): 294-99.
10. Myers TG, Anderson NL, Waltham M et al. A protein expression database for the molecular pharmacology of cancer. Electrophoresis 1997; 18(3-4): 647-53.
11. Leonessa F, Green D, Licht T etal. MDA435/LCC6 and MDA435/LCC6MDR1: ascites models of human breast cancer. Br J Cancer 1996; 73(2): 154-61.
12. Scudiero DA, Monks A, Sausville EA. Cell line designation change: Multidrug-resistant cell line in the NCI anticancer screen. J Natl Cancer Inst 1998; 90(11): 862.
13. Ackland ML, Newgreen D, Price JT et al. Epidermal growth factor stimulates epithelio-mesenchymal transition in the stable human breast carcinoma cell line variant PMC42-LA. Lab Invest 2003; 83(3): 435-48.
14. Kallioniemi OP, Kallioniemi A, Piper J et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 1994; 10(4): 231-43.
15. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 1998; 95(25): 14863-68.
16. Takeo S, Arai H, Kusano N et al. Examination of oncogene amplification by genomic DNA microarray in hepatocellular carcinomas: comparison with comparative genomic hybridization analysis. Cancer Genet Cytogenet 2001; 130(2): 127-32.
17. Rae JM, Cordero KE, Scheys JO et al. Genotyping for polymorphic drug metabolizing enzymes from paraffin-embedded and immunohistochemically stained tumor samples. Pharmacogenetics 2003; 13(8): 501-507.
18. Davidson JM, Gorringe KL, Chin SF et al. Molecular cytogenetic analysis of breast cancer cell lines. Br J Cancer 2000; 83(10): 1309-17.
19. Sellappan S, Grijalva R, Zhou X et al. Lineage infidelity of MDA-MB-435 cells: Expression of melanocyte proteins in a breast cancer cell line. Cancer Res 2004; 64(10): 3479-85.
20. Welch DR, Krizman DB, Nicolson GL. Multiple phenotypic divergence of mammary adenocarcinoma cell clones. I. In vitro and in vivo properties. Clin Exp Metast 1984; 2(4): 333-355.
21. Welch DR, Evans DP, Tomasovic SP et al. Multiple phenotypic divergence of mammary adenocarcinoma cell clones. II. Sensitivity to radiation, hyperthermia and FUdR. Clin Exp Metast 1984; 2(4): 357-71.
22. Welch DR, Nicolson GL. Phenotypic drift and heterogeneity in response of metastatic mammary adenocarcinoma cell clones to adriamycin, 5-fluoro-2′-deoxyuridine and methotrexate treatment in vitro. Clin Exp Metast 1983; 1(4): 317-25.
23. Welch DR, Milas L, Tomasovic SP, Nicolson GL. Heterogeneous response and clonal drift of sensitivities of metastatic 13762NF mammary adenocarcinoma clones to gamma-radiation in vitro. Cancer Res 1983; 43(1): 6-10.
24. Bahia H, Ashman JN, Cawkwell L et al. Karyotypic variation between independently cultured strains of the cell line MCF-7 identified by multicolour fluorescence in situ hybridization. Int J Oncol 2002; 20(3): 489-94.
25. Gilles C, Thompson EW. The epithelial to mesenchymal transition and metastatic progression in carcinoma. The Breast J 1996; 2: 83-96.
26. Thiery JP. Epithelial to mesenchymal transitions in tumour progression. Nat Cancer 2002; 2: 442-54.
27. Hendrix MJ, Seftor EA, Kirschmann DA, Seftor RE. Molecular biology of breast cancer metastasis. Molecular expression of vascular markers by aggressive breast cancer cells. Breast Cancer Res 2000; 2(6): 417-22.
28. Satya-Prakash KL, Pathak S, Hsu TC et al. Cytogenetic analysis on eight human breast tumor cell lines: high frequencies of 1q, 11q and HeLa-like marker chromosomes. Cancer Genet Cytogenet 1981; 3(1): 61-73.
29. Price JE. Analyzing the metastatic phenotype. J Cell Biochem 1994; 56(1): 16-22.
30. Thompson EW, Waltham M, Ramus SJ et al. LCC15-MB cells are MDA-MB-435: A review of misidentified breast and prostate cell lines. Clin Exp Metast 2004; 21(6): 535-41 (this issue).
31. Ramus SJ, Pharoah PD, Harrington P et al. BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases. Cancer Res 2003; 63(2): 417-23.